Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Granulomatous Disease, Chronic

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Granulomatous Disease, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elsner, J; Emmendörffer, A; Lohmann-Matthes, ML; Meier, B; Raeder, E; Roesler, J1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Granulomatous Disease, Chronic

ArticleYear
Production of oxygen radicals by fibroblasts and neutrophils from a patient with x-linked chronic granulomatous disease.
    European journal of haematology, 1993, Volume: 51, Issue:4

    Topics: Calcimycin; Cells, Cultured; Child; Cytochrome b Group; Female; Fibroblasts; Granulomatous Disease, Chronic; Humans; Interleukin-1; Kinetics; Male; NADPH Oxidases; Neutrophils; Platelet Activating Factor; Reference Values; Skin; Superoxides; Tumor Necrosis Factor-alpha; X Chromosome

1993